These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18284599)

  • 21. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.
    Hryszko T; Malyszko J; Malyszko JS; Brzosko S; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Aug; 16(8):1692-6. PubMed ID: 11477176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
    Bajzar L; Nesheim ME; Tracy PB
    Blood; 1996 Sep; 88(6):2093-100. PubMed ID: 8822928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
    Bajzar L; Jain N; Wang P; Walker JB
    Crit Care Med; 2004 May; 32(5 Suppl):S320-4. PubMed ID: 15118538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets.
    Schadinger SL; Lin JH; Garand M; Boffa MB
    J Thromb Haemost; 2010 Nov; 8(11):2523-9. PubMed ID: 20723026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinin system, blood coagulation and fibrinolysis in glomerulonephritis].
    Alekseev GI; Bobrov LL
    Klin Med (Mosk); 1979 Jul; 57(7):72-6. PubMed ID: 480888
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitors of chemotaxis.
    Maderazo EG; Woronick CL; Ward PA
    Methods Enzymol; 1988; 162():223-35. PubMed ID: 3226307
    [No Abstract]   [Full Text] [Related]  

  • 27. Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis.
    Mochizuki L; Sano H; Honkura N; Masumoto K; Urano T; Suzuki Y
    Thromb Haemost; 2023 Jan; 123(1):16-26. PubMed ID: 36307100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice.
    Morser J; Shao Z; Nishimura T; Zhou Q; Zhao L; Higgins J; Leung LLK
    J Thromb Haemost; 2018 May; 16(5):991-1002. PubMed ID: 29383821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L
    Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L; Nesheim M; Morser J; Tracy PB
    J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH; Kim P; Nesheim ME
    J Biol Chem; 2008 Apr; 283(14):8863-7. PubMed ID: 18252711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
    Wu C; Stafford AR; Fredenburgh JC; Weitz JI; Gils A; Declerck PJ; Kim PY
    Thromb Haemost; 2017 Jul; 117(8):1509-1517. PubMed ID: 28640323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models.
    Leenaerts D; Loyau S; Mertens JC; Boisseau W; Michel JB; Lambeir AM; Jandrot-Perrus M; Hendriks D
    J Thromb Haemost; 2018 Oct; 16(10):2057-2069. PubMed ID: 30053349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of carboxypeptidase in regulation of fibrinolysis].
    Samokhin AA; Kudinov SA
    Ukr Biokhim Zh (1999); 2005; 77(6):8-15. PubMed ID: 19618737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase.
    Fogg DK; Bridges DE; Cheung KK; Kassam G; Filipenko NR; Choi KS; Fitzpatrick SL; Nesheim M; Waisman DM
    Biochemistry; 2002 Apr; 41(15):4953-61. PubMed ID: 11939791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN; Marx PF; Mosnier LO; Meijers JC
    Thromb Res; 2001 Mar; 101(5):329-54. PubMed ID: 11297751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on coagulation-fibrinolysis and kallikrein-kinin systems and kininase activity and kininase II quantity in amniotic fluid.
    Mutoh S; Yaoi Y; Teh A; Saito M; Aoki N; Abe T; Ohno Y; Itoh N
    Adv Exp Med Biol; 1989; 247B():559-67. PubMed ID: 2558521
    [No Abstract]   [Full Text] [Related]  

  • 38. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M; Werner M; Wang M; Zhao L; Light DR; Pagila R; Morser J; Verhallen P
    Thromb Res; 2000 May; 98(4):333-42. PubMed ID: 10822080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
    Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic activation of purified human procarboxypeptidase U.
    Schatteman KA; Goossens FJ; Scharpé SS; Hendriks DF
    Clin Chim Acta; 2000 Feb; 292(1-2):25-40. PubMed ID: 10686274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.